Literature DB >> 11494049

Galectin-8: a complex sub-family of galectins (Review).

N Bidon1, F Brichory, P Bourguet, J P Le Pennec, L Dazord.   

Abstract

Galectins are animal lectins, that can specifically bind beta-galactosides. Twelve galectins have been described in vertebrates, belonging to three different groups: prototype, tandem-repeat and chimeric. These proteins seem to be involved in cellular interactions and neoplastic transformations. We present an overview of a particular galectin member: galectin-8. This galectin, which has been intensively studied over the last six years, presents a particular type of gene regulation. It is widely expressed in tumoral tissues and seems to be involved in integrin-like cell interactions. Studies show that the LGALS8 gene encodes for almost seven mRNAs by alternative splicing pathways and various polyadenylation sites. These mRNAs could encode for six isoforms of galectin-8, of which three belong to the tandem-repeat galectin group (with two carbohydrate binding domains) and the three others to the prototype group (one carbohydrate binding domain). All these isoforms seem to be differentially expressed in various tumoral cells. This untypical galectin-8 subfamily seems to have a complex expression regulation, that could be involved in cancer phenomena.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494049     DOI: 10.3892/ijmm.8.3.245

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  19 in total

Review 1.  Insect galectins: roles in immunity and development.

Authors:  Karen E Pace; Linda G Baum
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Galectin genes: regulation of expression.

Authors:  Lorenzo Chiariotti; Paola Salvatore; Rodolfo Frunzio; Carmelo B Bruni
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  Galectin multimerization and lattice formation are regulated by linker region structure.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  Glycobiology       Date:  2010-09-23       Impact factor: 4.313

Review 4.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

5.  Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.

Authors:  Sean R Stowell; Connie M Arthur; Kristin A Slanina; John R Horton; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

Review 6.  Tumor galectinology: insights into the complex network of a family of endogenous lectins.

Authors:  Harald Lahm; Sabine André; Andreas Hoeflich; Herbert Kaltner; Hans-Christian Siebert; Bernard Sordat; Claus-Wilhelm von der Lieth; Eckhard Wolf; Hans-Joachim Gabius
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation.

Authors:  Andrés Norambuena; Claudia Metz; Lucas Vicuña; Antonia Silva; Evelyn Pardo; Claudia Oyanadel; Loreto Massardo; Alfonso González; Andrea Soza
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

8.  Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Exp Cell Res       Date:  2009-03-04       Impact factor: 3.905

Review 9.  Role of galectin-8 as a modulator of cell adhesion and cell growth.

Authors:  Yehiel Zick; Miriam Eisenstein; Rinat A Goren; Yaron R Hadari; Yifat Levy; Denise Ronen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

10.  Galectin-8 expression in laryngeal squamous cell carcinoma.

Authors:  Geun Woo Dong; Jun Kim; Jun Hee Park; Ji Yun Choi; Sung Il Cho; Sung Chul Lim
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-03-26       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.